PatientsVille.com Logo

PatientsVille

Emconcor Side Effects

Common Emconcor Side Effects


The most commonly reported Emconcor side effects (click to view or check a box to report):

Abdominal Pain Upper (3)
Loss Of Consciousness (3)
Renal Failure Acute (2)
Lymphadenopathy (2)
Squamous Cell Carcinoma (2)
Hypotension (2)
Hepatocellular Injury (2)
Asthenia (2)
Electrocardiogram Qt Prolonged (2)
Fatigue (2)
Compartment Syndrome (2)
Anuria (2)
Chest Pain (2)
Cholecystectomy (2)
Colectomy (2)
Cardiac Failure (2)
Abortion Spontaneous (2)
Alanine Aminotransferase Increased (2)
Bradycardia (2)
Duodenal Perforation (2)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Emconcor Side Effects Reported to FDA

The following Emconcor reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Emconcor on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Fatigue, Abdominal Pain Upper, Pain In Extremity, Muscle Spasms, Loss Of Consciousness, Oedema Peripheral
This is a report of a male patient (weight: NA) from FINLAND, suffering from the following symptoms/conditions: hypertension,haemangioma congenital, who was treated with Emconcor Comp (dosage: NA, start time: Jan 01, 2011), combined with:
  • Firazyr
  • Tranexamic Acid
  • Lercanidipine
  • Cyklokapron
and developed a serious reaction and side effect(s). The consumer presented with:
  • Fatigue
  • Abdominal Pain Upper
  • Pain In Extremity
  • Muscle Spasms
  • Loss Of Consciousness
  • Oedema Peripheral
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Emconcor Comp treatment in male patients, resulting in fatigue side effect. The patient was hospitalized.

Lymphadenopathy, Squamous Cell Carcinoma
This report suggests a potential Emconcor Comp Lymphadenopathy, Squamous Cell Carcinoma side effect(s) that can have serious consequences. A 53-year-old male patient (weight: NA) from FINLAND was diagnosed with the following symptoms/conditions: blood pressure and used Emconcor Comp (dosage: 1 Tablet Daily) starting Jan 01, 2009. Soon after starting Emconcor Comp the patient began experiencing various side effects, including:
  • Lymphadenopathy
  • Squamous Cell Carcinoma
Drugs used concurrently:
  • Betamethasone Dipropionate/calcipotriol (Once Daily)
  • Raptiva (1 Dose Weekly)
  • Enbrel (50 Mg, Weekly)
  • Enbrel
  • Diapam /00017001/ (Once Daily, If Needed)
The patient was hospitalized. Although Emconcor Comp demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as lymphadenopathy, may still occur.

Fatigue, Disorientation, C-reactive Protein Increased, Swelling, Eye Infection, Stridor, Pyrexia, Ocular Hyperaemia
This Fatigue, Disorientation, C-reactive Protein Increased, Swelling, Eye Infection, Stridor, Pyrexia, Ocular Hyperaemia problem was reported by a physician from FINLAND. A 96-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: cardiac failure,prophylaxis. On Dec 10, 2011 this consumer started treatment with Emconcor Chf (dosage: 1.25 Mg, 1x/day). The following drugs were being taken at the same time:
  • Omeprazole (20 Mg, 1x/day)
  • Lyrica (75 Mg, 1x/day)
  • Lyrica (25 Mg, 1x/day)
  • Lyrica (75 Mg, 1x/day)
  • Furesis (40 Mg, 1x/day)
  • Medrol (8 Mg, 1x/day)
  • Para-tabs (500 Mg, 3x/day)
  • Levolac (20 Ml, 1x/day)
When commencing Emconcor Chf, the patient experienced the following unwanted symptoms/side effects:
  • Fatigue
  • Disorientation
  • C-reactive Protein Increased
  • Swelling
  • Eye Infection
  • Stridor
  • Pyrexia
  • Ocular Hyperaemia
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as fatigue, may become evident only after a product is in use by the general population.

Lymphadenopathy, Squamous Cell Carcinoma
This is a report of a 53-year-old male patient (weight: NA) from FINLAND. The patient developed the following symptoms/conditions: blood pressure and was treated with Emconcor Comp (dosage: 1 Tablet Daily) starting Jul 01, 2007. Concurrently used drugs:
  • Betamethasone Dipropionate/calcipotriol (Once Daily)
  • Diapam /00017001/ (Once Daily, If Needed)
  • Raptiva (Unk Unk, Qwk)
  • Enbrel (50 Mg, Weekly)
Soon after that, the consumer experienced the following side effects:
  • Lymphadenopathy
  • Squamous Cell Carcinoma
The patient was hospitalized. This opens a possibility that Emconcor Comp treatment could cause the above reactions, including lymphadenopathy, and some male subjects may be more susceptible.


Pulmonary Embolism, Chest Pain
A male patient (weight: NA) from BELGIUM with the following symptoms/conditions: hypertension,pain started Emconcor Mitis treatment (dosage: Daily Dose 5 Mg) on May 19, 2011. Soon after starting Emconcor Mitis treatment, the subject experienced various side effects, including:
  • Pulmonary Embolism
  • Chest Pain
Concurrently used drugs:
  • Acetaminophen (Daily Dose 500 Mg)
  • Nexavar (Daily Dose 600 Mg)
  • Cardioaspirine
  • Capecitabine (Daily Dose 1650 Mg)
  • Amlodipine Besylate (Daily Dose 5 Mg)
  • Crestor (Daily Dose 10 Mg)
The patient was hospitalized. This finding indicates that some male patients could be more vulnerable to Emconcor Mitis.

Atrial Fibrillation, Viral Infection, Swelling Face
A 65-year-old female patient from SWEDEN (weight: NA) experienced symptoms, such as: NA and was treated with Emconcor(dosage: NA). The treatment was initiated on Aug 01, 2010. After that a consumer reported the following side effect(s):
  • Atrial Fibrillation
  • Viral Infection
  • Swelling Face
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Emconcor efficacy:
  • Orencia (Authorization Number:125118 17feb11-8th Inf 1apr11-9th Inf 500mg)
The patient was hospitalized.

Constipation, Increased Bronchial Secretion, Urticaria, Hypersensitivity, Bronchitis, Pneumonia
In this report, Emconcor /00802601/ was administered for the following condition: NA.A 85-year-old female consumer from FINLAND (weight: NA) started Emconcor /00802601/ treatment (dosage: 2.5 Mg, Qd) on Feb 09, 2011.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Constipation
  • Increased Bronchial Secretion
  • Urticaria
  • Hypersensitivity
  • Bronchitis
  • Pneumonia
A possible interaction with other drugs could have contributed to this reaction:
  • Kalcipos-d
  • Prolia (60 Mg, Unk)
Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Emconcor /00802601/ treatment could be related to the listed above side effect(s).

Renal Failure Acute
This is a report of the following Emconcor side effect(s):
  • Renal Failure Acute
A 54-year-old male patient from SPAIN (weight: NA) presented with the following condition: NA and received a treatment with Emconcor (dosage: 5 Mg, 1x/day) starting: Apr 01, 2006.The following concurrently used drugs could have generated interactions:
  • Manidipine Hydrochloride (20 Mg, 1x/day)
  • Cardura (4 Mg, 1x/day)
  • Aprovel (300 Mg, 1x/day)
  • Metformin (850 Mg, 1x/day)
  • Humalog (47 Iu, Unk)
The patient was hospitalized.This report suggests that a Emconcor treatment could be associated with the listed above side effect(s).

Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Hepatocellular Injury, Gamma-glutamyltransferase Increased, Asthenia
This Emconcor Chf report was submitted by a 65-year-old female consumer from FINLAND (weight: NA). The patient was diagnosed with: NA and Emconcor Chf was administered (dosage: NA) starting: Oct 25, 2010. The consumer developed a set of symptoms:
  • Alanine Aminotransferase Increased
  • Aspartate Aminotransferase Increased
  • Hepatocellular Injury
  • Gamma-glutamyltransferase Increased
  • Asthenia
Other drugs used simultaneously:
  • Warfarin Sodium
  • Multaq
  • Atacand
Those unexpected symptoms could be linked to a Emconcor Chf treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Pneumonia Aspiration, Implant Site Haemorrhage
This is a report of a possible correlation between Emconcor use and the following symptoms/side effect(s):
  • Pneumonia Aspiration
  • Implant Site Haemorrhage
which could contribute to an assessment of Emconcor risk profile.A 65-year-old male consumer from UNITED STATES (weight: NA) was suffering from hypertension,prophylaxis,nausea,head and neck cancer and was treated with Emconcor (dosage: NA) starting Apr 26, 2010.Other concurrent medications:
  • Dafalgan
  • Primperan Tab
  • Alimta (Vial.last Dose On 30jul2010(4th Cycle)
  • Vitamin B-12
  • Dexamethasone
  • Cisplatin (Last Dose On 30jul2010(4th Cycle)
  • Zantac
  • Lexotan
The patient was hospitalized.

Arthralgia, Abdominal Pain, Vomiting, Jaundice, Hepatocellular Injury, Renal Failure, Asthenia, Pruritus, Blood Creatinine Increased
A 85-year-old female patient from SPAIN (weight: NA) presented with the following symptoms: atrial fibrillation and after a treatment with Emconcor /spa/ (dosage: NA) experienced the following side effect(s):
  • Arthralgia
  • Abdominal Pain
  • Vomiting
  • Jaundice
  • Hepatocellular Injury
  • Renal Failure
  • Asthenia
  • Pruritus
  • Blood Creatinine Increased
The treatment was started on Oct 21, 2010. Emconcor /spa/ was used in combination with the following drugs:
  • Somazina
  • Multaq
  • Multaq
  • Seguril
  • Lexatin
  • Spironolactone
  • Atacand
  • Sintrom
The patient was hospitalized.This report could alert potential Emconcor /spa/ consumers.

Cardiovascular Insufficiency, Hypotension, Pulmonary Oedema, Cardiac Failure
In this report, a 85-year-old male patient from SWEDEN (weight: NA) was affected by a possible Emconcor side effect.The patient was diagnosed with NA. After a treatment with Emconcor (dosage: 1.25 Mg, Unk, start date: Apr 27, 2009), the patient experienced the following side effect(s):
  • Cardiovascular Insufficiency
  • Hypotension
  • Pulmonary Oedema
  • Cardiac Failure
The following simultaneously used drugs could have led to this reaction:
  • Alfadil (4 Mg, 1x/day)
  • Prednisolone (30mg Daily With Reductive Dose 5mg/day)
  • Zopiklon Nm Pharma (5 Mg, Unk)
  • Pramace (1.25 Mg, 1x/day)
  • Trombyl (300 Mg, 1x/day)
  • Velcade (2.4 Mg, Two Times A Week For 2 Weeks)
  • Plavix (300 Mg, 1x/day)
  • Heparin (4000 Iu, 1x/day)
The findings here stress that side effects should be taken into consideration when evaluating a Emconcor treatment.

Cardiac Failure, Off Label Use
This is a report of a patient from SPAIN (weight: NA), who used Emconcor (dosage: 5 Mg, 2/d) for a treatment of cardiac disorder. After starting a treatment on Dec 22, 2010, the patient experienced the following side effect(s):
  • Cardiac Failure
  • Off Label Use
The following drugs could possibly have interacted with the Emconcor treatment
  • Uniket (40 Mg, 2/d)
  • Omeprazole (1 D/f, Daily (1/d))
  • Forteo (20 Ug, Daily (1/d))
  • Beclomethasone W/fenoterol (Unk, 2/d)
  • Micardis (1 D/f, Daily (1/d))
  • Pravastatina (1 D/f, Daily (1/d))
  • Ventolin Es (Unk, As Needed)
  • Metformin Hcl (850 Mg, Every 8 Hrs)
The patient was hospitalized.Taken together, these observations suggest that a Emconcor treatment could be related to side effect(s), such as Cardiac Failure, Off Label Use.

Atrioventricular Block, Syncope
This atrioventricular block side effect was reported by a consumer or non-health professional from SPAIN. A 81-year-old female patient (weight:NA) experienced the following symptoms/conditions: atrial fibrillation. The patient was prescribed Emconcor (2.5 Mg) (bisoprolol Fumarate) (dosage: 2.5 Mg (2.5 Mg, 1 In 1 D) Oral), which was started on NS. Concurrently used drugs:
  • Digoxin (0.25 Mg Oral)
  • Torsemide
  • Enalapril Maleate
  • Gabapentin
  • Acenocoumarol (acenocoumarol)
When starting to take Emconcor (2.5 Mg) (bisoprolol Fumarate) the consumer reported the following symptoms:
  • Atrioventricular Block
  • Syncope
The patient was hospitalized. These side effects may potentially be related to Emconcor (2.5 Mg) (bisoprolol Fumarate).

Bradycardia, Convulsion
This is a Emconcor (film-coated Tablet) (bisoprolol Fumarate) side effect report of a 81-year-old female patient (weight:NA) from SWEDEN, suffering from the following symptoms/conditions: essential hypertension, who was treated with Emconcor (film-coated Tablet) (bisoprolol Fumarate) (dosage:5 Mg (5mg); Oral, start time: NS), combined with:
  • Zolpidem Actavis (zolpidem)
  • Enalapril Actavis (enalapril)
  • Omeprazol Abcur (omeprazole)
  • Hydrokortison Nycomed (hydrocortisone)
  • Alenat (alendronate Sodium)
  • Nulytely
  • Simvastatin Actavis (simvastatin)
  • Levothyroxine Sodium
, and developed a serious reaction and a bradycardia side effect. The patient presented with:
  • Bradycardia
  • Convulsion
which developed after the beginning of treatment. The patient was hospitalized. This side effect report can indicate a possible existence of increased vulnerability to Emconcor (film-coated Tablet) (bisoprolol Fumarate) treatment in female patients suffering from essential hypertension, resulting in bradycardia.

Atrioventricular Block Second Degree
This report suggests a potential Emconcor (tablet) (bisoprolol Fumarate) atrioventricular block second degree side effect(s) that can have serious consequences. A 87-year-old female patient from SPAIN (weight:NA) was diagnosed with the following health condition(s): hypertension and used Emconcor (tablet) (bisoprolol Fumarate) (dosage: (10 Mg) Oral) starting NS. Soon after starting Emconcor (tablet) (bisoprolol Fumarate) the patient began experiencing various side effects, including:
  • Atrioventricular Block Second Degree
Drugs used concurrently:
  • Lercadip (lercanidipine)
  • Lorazepam
  • Micardis Plus (hydrochlorothiazide, Telmisartan)
  • Omeprazole
  • Fexofenadine Hcl
The patient was hospitalized. Although Emconcor (tablet) (bisoprolol Fumarate) demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as atrioventricular block second degree, may still occur.

Blood Pressure Decreased, Chest Pain, Electrocardiogram Qt Prolonged, Heart Rate Decreased, Loss Of Consciousness
This blood pressure decreased problem was reported by a health professional from SWEDEN. A 84-year-old male patient (weight: NA) was diagnosed with the following medical condition(s): essential hypertension.On Oct 01, 2007 a consumer started treatment with Emconcor (film-coated Tablet) (bisoprolol Fumarate) (dosage: NA). The following drugs/medications were being taken at the same time:
  • Alfadil (prolonged-release Tablet) (doxazosin Mesilate)
When commencing Emconcor (film-coated Tablet) (bisoprolol Fumarate), the patient experienced the following unwanted symptoms /side effects:
  • Blood Pressure Decreased
  • Chest Pain
  • Electrocardiogram Qt Prolonged
  • Heart Rate Decreased
  • Loss Of Consciousness
The patient was hospitalized. Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as blood pressure decreased, may become evident only after a product is in use by the general population.

Alanine Aminotransferase Increased, Brain Natriuretic Peptide Increased, Haemoglobin Decreased, Hyponatraemia, Hypotension, International Normalised Ratio Increased, Prothrombin Level Decreased
This is a Emconcor (5 Mg, Film-coated Tablet) (bisoprolol Fumarate) side effect report of a 84-year-old male patient (weight: NA) from SWEDEN. The patient developed the following symptoms/conditions: cardiac failure,atrial fibrillation and was treated with Emconcor (5 Mg, Film-coated Tablet) (bisoprolol Fumarate) (dosage: Oral) starting NS. Concurrently used drugs:
  • Waran (2,5 Mg, Tablet) (warfarin Sodium) (2,5 Mg)
  • Waran (2,5 Mg, Tablet) (warfarin Sodium) (2,5 Mg)
  • Impugan (500 Mg, Tablet) (furosemide) (500 Mgd (500 Mg) , Oral : Reduced Dose (500 Mg)
  • Simvastatin
Soon after that, the consumer experienced the following of symptoms:
  • Alanine Aminotransferase Increased
  • Brain Natriuretic Peptide Increased
  • Haemoglobin Decreased
  • Hyponatraemia
  • Hypotension
  • International Normalised Ratio Increased
  • Prothrombin Level Decreased
The patient was hospitalized. This opens a possibility that Emconcor (5 Mg, Film-coated Tablet) (bisoprolol Fumarate) could cause alanine aminotransferase increased and that some male patients may be more susceptible.

Hyperkalaemia, Renal Failure Acute
A 79-year-old female patient (weight: NA) from SPAIN with the following symptoms: NA started Emconcor (bisoprolol Fumarate) treatment (dosage: Oral) on Aug 20, 2007. Soon after starting Emconcor (bisoprolol Fumarate) treatment, the consumer experienced several side effects, including:
  • Hyperkalaemia
  • Renal Failure Acute
. Concurrently used drugs:
  • Seguril (40 Mg, Tablet), (furosemide) (80 Mg (40 Mg, 2 In 1 D) Oral)
  • Aldactone (100 Mg, Tablet) (spironolactone) (Oral)
  • Omeprazole (20 Mg) (omeprazole)
  • Cozaar (50 Mg, Tablet) (losartan Potassium)
  • Sertraline (20 Mg) (sertraline)
The patient was hospitalized. This finding indicates that some patients can be more vulnerable to developing Emconcor (bisoprolol Fumarate) side effects, such as hyperkalaemia.

Abortion Spontaneous
This abortion spontaneous side effect was reported by a physician from . A 39-year-old female patient (weight:NA) experienced the following symptoms/conditions: cardiac disorder.The patient was prescribed Emconcor (dosage: NA), which was started on Oct 26, 2006. Concurrently used drugs:
  • Effexor
  • Xanax
  • Zyprexa
  • Zyprexa
  • Zyprexa
.When starting to take Emconcor the consumer reported symptoms, such as:
  • Abortion Spontaneous
These side effects may potentially be related to Emconcor.

Abortion Spontaneous
This is a report of a 39-year-old female patient (weight: NA) from , suffering from the following symptoms/conditions: cardiac disorder, who was treated with Emconcor (dosage: NA, start time: Oct 26, 2006), combined with:
  • Effexor
  • Xanax
  • Zyprexa
  • Zyprexa
  • Zyprexa
and developed a serious reaction and side effect(s). The consumer presented with:
  • Abortion Spontaneous
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Emconcor treatment in female patients, resulting in abortion spontaneous side effect.

Abdominal Pain Upper, Anuria, Cholecystectomy, Colectomy, Compartment Syndrome, Duodenal Fistula, Duodenal Perforation, Gallbladder Disorder, Ileostomy
This report suggests a potential Emconcor Abdominal Pain Upper, Anuria, Cholecystectomy, Colectomy, Compartment Syndrome, Duodenal Fistula, Duodenal Perforation, Gallbladder Disorder, Ileostomy side effect(s) that can have serious consequences. A 54-year-old male patient (weight: NA) from FINLAND was diagnosed with the following symptoms/conditions: atrial fibrillation,retinal artery thrombosis,hypercholesterolaemia and used Emconcor (dosage: 5 Mg/day) starting May 06, 2006. Soon after starting Emconcor the patient began experiencing various side effects, including:
  • Abdominal Pain Upper
  • Anuria
  • Cholecystectomy
  • Colectomy
  • Compartment Syndrome
  • Duodenal Fistula
  • Duodenal Perforation
  • Gallbladder Disorder
  • Ileostomy
Drugs used concurrently:
  • Marevan (3 Mg/day)
  • Canef (licensed To Astra) (40 Mg, Qd)
The patient was hospitalized and became disabled. Although Emconcor demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as abdominal pain upper, may still occur.

Abdominal Pain Upper, Anuria, Cholecystectomy, Colectomy, Compartment Syndrome, Duodenal Perforation, Intestinal Ischaemia, Laparotomy, Loss Of Consciousness
This Abdominal Pain Upper, Anuria, Cholecystectomy, Colectomy, Compartment Syndrome, Duodenal Perforation, Intestinal Ischaemia, Laparotomy, Loss Of Consciousness problem was reported by a consumer or non-health professional from FINLAND. A 54-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: atrial fibrillation,retinal artery thrombosis,hypercholesterolaemia. On Jan 01, 1987 this consumer started treatment with Emconcor (dosage: 2.5 Mg/day). The following drugs were being taken at the same time:
  • Marevan (According To Inr)
  • Canef (licensed To Astra) (40 Mg, Qd)
When commencing Emconcor, the patient experienced the following unwanted symptoms/side effects:
  • Abdominal Pain Upper
  • Anuria
  • Cholecystectomy
  • Colectomy
  • Compartment Syndrome
  • Duodenal Perforation
  • Intestinal Ischaemia
  • Laparotomy
  • Loss Of Consciousness
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as abdominal pain upper, may become evident only after a product is in use by the general population.

Gastrointestinal Haemorrhage
This is a report of a 67-year-old male patient (weight: NA) from . The patient developed the following symptoms/conditions: NA and was treated with Emconcor Cor 1.25 (bisoprolol) (dosage: Oral) starting Jun 26, 2004. Concurrently used drugs:
  • Tromalyt (acetylsalicylic Acid) (150 Mg (150 Mg, 1 In 1 D))
  • Plavix (75 Mg (75 Mg, 1 In 1 D))
  • Atorvastatin Calcium (20 Mg (20 Mg, 1 In 1 D))
  • Enalapril Maleate
  • Omnic (tamsulosin Hydrochloride)
Soon after that, the consumer experienced the following side effects:
  • Gastrointestinal Haemorrhage
The patient was hospitalized. This opens a possibility that Emconcor Cor 1.25 (bisoprolol) treatment could cause the above reactions, including gastrointestinal haemorrhage, and some male subjects may be more susceptible.

Atrioventricular Block
A 88-year-old female patient (weight: NA) from with the following symptoms/conditions: NA started Emconcor Cor 2.5 Mg (bisoprolol) treatment (dosage: 2,5 Mg (2,5 Mg, 1 In 1 D)) on NS. Soon after starting Emconcor Cor 2.5 Mg (bisoprolol) treatment, the subject experienced various side effects, including:
  • Atrioventricular Block
Concurrently used drugs:
  • Plavix
  • Ramipril
  • Anagrasta (pantoprazole Sodium)
  • Lipemol (pravastatin Sodium)
  • Furosemide
The patient was hospitalized. This finding indicates that some female patients could be more vulnerable to Emconcor Cor 2.5 Mg (bisoprolol).

1 of 2 



Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Emconcor Side Effects

    Did You Have a Emconcor Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Emconcor for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Emconcor Safety Alerts, Active Ingredients, Usage Information

    More About Emconcor

    Side Effects reported to FDA: 26

    Emconcor safety alerts: No

    Reported deaths: 2

    Reported hospitalizations: 7

    Latest Emconcor clinical trials